De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 1.164
EU - Europa 1.011
AS - Asia 921
SA - Sud America 237
AF - Africa 29
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.369
Nazione #
US - Stati Uniti d'America 1.141
SG - Singapore 460
DE - Germania 364
CN - Cina 230
SE - Svezia 223
BR - Brasile 202
IT - Italia 76
FR - Francia 71
GB - Regno Unito 65
IE - Irlanda 50
VN - Vietnam 45
UA - Ucraina 44
ID - Indonesia 41
IN - India 40
FI - Finlandia 32
RU - Federazione Russa 27
IQ - Iraq 20
BD - Bangladesh 15
TR - Turchia 14
AR - Argentina 12
AT - Austria 10
PL - Polonia 10
CI - Costa d'Avorio 9
JP - Giappone 9
BE - Belgio 8
HK - Hong Kong 8
CA - Canada 6
CL - Cile 6
MA - Marocco 6
NL - Olanda 6
IL - Israele 5
IR - Iran 5
JO - Giordania 5
MX - Messico 5
ZA - Sudafrica 5
EC - Ecuador 4
KR - Corea 4
NP - Nepal 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TN - Tunisia 3
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
MD - Moldavia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LY - Libia 1
MK - Macedonia 1
NA - Namibia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
Totale 3.369
Città #
Chandler 299
Singapore 235
Ashburn 90
Beijing 64
Dublin 50
Los Angeles 38
New York 37
Wilmington 37
Jakarta 36
San Mateo 36
Jacksonville 33
Nürnberg 31
Boston 27
Nanjing 22
Milan 20
Princeton 19
Ann Arbor 18
Moscow 18
Munich 18
Hanoi 17
São Paulo 17
Dallas 15
Cattolica 14
Frankfurt am Main 14
Helsinki 14
Nanchang 14
Dearborn 13
Norwalk 13
Chicago 12
Hefei 12
Ho Chi Minh City 12
Lawrence 11
Shanghai 11
Atlanta 10
Rome 10
Abidjan 9
Houston 9
Marseille 9
Rio de Janeiro 9
Bremen 8
Brussels 8
Buffalo 8
Falls Church 8
Hong Kong 8
London 8
Nuremberg 8
Brooklyn 7
Hebei 7
Baghdad 6
Chennai 6
Mountain View 6
Pune 6
Santa Clara 6
Woodbridge 6
Amman 5
Dhaka 5
Düsseldorf 5
Fairfield 5
Izmir 5
Kent 5
Lviv 5
Portsmouth 5
Tokyo 5
Amsterdam 4
Andover 4
Ankara 4
Caxias do Sul 4
Coquimbo 4
Fremont 4
Haiphong 4
Johannesburg 4
Leawood 4
Mumbai 4
Redwood City 4
Seattle 4
Seoul 4
São Gonçalo 4
Tehran 4
Turku 4
Vienna 4
Warsaw 4
Wroclaw 4
Auckland 3
Augusta 3
Brasília 3
Changchun 3
Chengdu 3
Curitiba 3
Denver 3
Edinburgh 3
Erbil 3
Fairport 3
Falkenstein 3
Florence 3
Fuzhou 3
Jiaxing 3
Kunming 3
Lancaster 3
Lappeenranta 3
Lauterbourg 3
Totale 1.654
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 237
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 168
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 150
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 141
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 138
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 134
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 129
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 113
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 105
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 104
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 100
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 99
A unique case of multiphasic ADEM or what else? 99
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 98
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 97
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 97
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 96
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 93
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 93
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 89
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 87
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 86
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 84
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 81
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 79
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 78
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 78
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 77
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 74
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 70
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 67
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 66
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 64
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 52
Totale 3.423
Categoria #
all - tutte 15.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 6 8 4 12 8 30 7
2021/2022315 30 5 4 42 12 13 0 48 18 20 45 78
2022/2023708 94 107 60 119 36 86 29 58 69 9 27 14
2023/2024266 16 73 7 7 10 33 20 9 7 10 29 45
2024/2025563 18 22 50 30 31 33 11 19 83 45 126 95
2025/2026850 232 40 86 161 322 9 0 0 0 0 0 0
Totale 3.423